[
  {
    "ts": null,
    "headline": "FDA Approves Updated Label For Eli Lilly and Company (LLY)’s Amyvid To Support Alzheimer’s Diagnosis",
    "summary": "Eli Lilly and Company (NYSE:LLY) is among the Goldman Sachs Stock Portfolio: 10 Large-Cap Stocks To Buy. On June 25, the company announced that the FDA had approved a label update for Amyvid to support the diagnosis of Alzheimer’s disease. The florbetapir F 18 injection is used for brain imaging of patients with cognitive impairment who […]",
    "url": "https://finnhub.io/api/news?id=3455926d13ff1b58cc8af96cc8cd4a88d9b60322a56e537f570e62ec340db169",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751317718,
      "headline": "FDA Approves Updated Label For Eli Lilly and Company (LLY)’s Amyvid To Support Alzheimer’s Diagnosis",
      "id": 135679799,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Eli Lilly and Company (NYSE:LLY) is among the Goldman Sachs Stock Portfolio: 10 Large-Cap Stocks To Buy. On June 25, the company announced that the FDA had approved a label update for Amyvid to support the diagnosis of Alzheimer’s disease. The florbetapir F 18 injection is used for brain imaging of patients with cognitive impairment who […]",
      "url": "https://finnhub.io/api/news?id=3455926d13ff1b58cc8af96cc8cd4a88d9b60322a56e537f570e62ec340db169"
    }
  },
  {
    "ts": null,
    "headline": "Can Protagonist Take On Eli Lilly's Next-Generation Obesity Treatment?",
    "summary": "Protagonist Therapeutics is taking aim directly at Eli Lilly's obesity treatment with a newly announced drug that uses the same mechanism.",
    "url": "https://finnhub.io/api/news?id=a41fbce3a267d3584c748a0066f35e342597111b0424027dbc0697f9b825d867",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751313901,
      "headline": "Can Protagonist Take On Eli Lilly's Next-Generation Obesity Treatment?",
      "id": 135677313,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Protagonist Therapeutics is taking aim directly at Eli Lilly's obesity treatment with a newly announced drug that uses the same mechanism.",
      "url": "https://finnhub.io/api/news?id=a41fbce3a267d3584c748a0066f35e342597111b0424027dbc0697f9b825d867"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly (LLY) Faces Bearish Options Flow, But Probabilities Tell a Different Story",
    "summary": "Options traders leaned bearish on LLY stock, but market demand data reveals conditional odds that may support near-term upside.",
    "url": "https://finnhub.io/api/news?id=8a3beb4ed668a0b57ecdfc37a3dae4bd144a841bf78634eac431f87ff784cf5f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751304602,
      "headline": "Eli Lilly (LLY) Faces Bearish Options Flow, But Probabilities Tell a Different Story",
      "id": 135671330,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Options traders leaned bearish on LLY stock, but market demand data reveals conditional odds that may support near-term upside.",
      "url": "https://finnhub.io/api/news?id=8a3beb4ed668a0b57ecdfc37a3dae4bd144a841bf78634eac431f87ff784cf5f"
    }
  },
  {
    "ts": null,
    "headline": "Will CVS Health's Formulary Move Boost Its Weight Management Program? (Revised)",
    "summary": "CVS adds Wegovy to its top formularies and bolsters its Weight Management program, aiming to expand access while cutting costs.",
    "url": "https://finnhub.io/api/news?id=1195d1c5183c46b4bfb2e8137f877465cceb36252b0fb31eef30b4fc80a7fc91",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751293620,
      "headline": "Will CVS Health's Formulary Move Boost Its Weight Management Program? (Revised)",
      "id": 135671331,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "CVS adds Wegovy to its top formularies and bolsters its Weight Management program, aiming to expand access while cutting costs.",
      "url": "https://finnhub.io/api/news?id=1195d1c5183c46b4bfb2e8137f877465cceb36252b0fb31eef30b4fc80a7fc91"
    }
  },
  {
    "ts": null,
    "headline": "RBC says Lilly could blaze trail and Biogen could pull ahead in Alzheimer’s market",
    "summary": "Investing.com -- RBC Capital Markets analysts believe Eli Lilly’s upcoming TRAILBLAZER-3 trial data on Kisunla could unlock a vast, largely untapped segment of the Alzheimer’s treatment market and pave the way for Biogen’s Leqembi to follow with significant commercial success.",
    "url": "https://finnhub.io/api/news?id=aa3fd58b3af4e34e4d99f93669cc36a6924b778285e9f813fadfcf28a283837d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751285932,
      "headline": "RBC says Lilly could blaze trail and Biogen could pull ahead in Alzheimer’s market",
      "id": 135671332,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Investing.com -- RBC Capital Markets analysts believe Eli Lilly’s upcoming TRAILBLAZER-3 trial data on Kisunla could unlock a vast, largely untapped segment of the Alzheimer’s treatment market and pave the way for Biogen’s Leqembi to follow with significant commercial success.",
      "url": "https://finnhub.io/api/news?id=aa3fd58b3af4e34e4d99f93669cc36a6924b778285e9f813fadfcf28a283837d"
    }
  },
  {
    "ts": null,
    "headline": "Wall Street Breakfast Podcast: UK Cars, Planes Get U.S. Break",
    "summary": "Wall Street Breakfast Podcast: UK Cars, Planes Get U.S. Break",
    "url": "https://finnhub.io/api/news?id=0bd7e6cae90643aa2ff2f02577c97b2614453a2e670ce13b76ae1f9fcfc81d88",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751266647,
      "headline": "Wall Street Breakfast Podcast: UK Cars, Planes Get U.S. Break",
      "id": 135649627,
      "image": "",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=0bd7e6cae90643aa2ff2f02577c97b2614453a2e670ce13b76ae1f9fcfc81d88"
    }
  }
]